Earnings NewsHealthcareResMed EPS in-line, beats on revenueJul. 28, 2016 4:10 PM ETResMed Inc. (RMD) StockBy: SA News Team ResMed (NYSE:RMD): FQ4 EPS of $0.74 in-line. Revenue of $518.65M (+14.5% Y/Y) beats by $4.68M. Press Release Recommended For YouMore Trending NewsSee More »About RMD StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgRMD--ResMed Inc.Trending AnalysisTrending News